ACACB has studied metabolic syndrome, obesity, colorectal cancer, diabetes diseases, lung cancer, and hepatocellular carcinoma (Svensson et al., 2016; Yu et al., 2018; Lally et al., 2019). This evidence concerns the gene ACACB and obesity due to melanocortin 4 receptor deficiency.